-
Study aim
-
Determining effect of advanced platelet-rich fibrin and rosuvastatin gel in the healing of extracted tooth socket
-
Design
-
Controlled clinical trial, with four-arm parallel-group, single-blinded, randomized, on 36 patients
-
Settings and conduct
-
Patients referring to the dental faculty of Guilan university of medical science are chosen if they have the inclusion criteria. Patients are divided into three intervention groups and one control group based on a table of random numbers. In group A, as a spontaneously healing control group, after tooth extraction and socket washing with normal saline, suturing was performed. Groups B, C, and D also include those who receive A-PRF +, Rosuvastatin, and a mix of A-PRF + and Rosuvastatin, respectively, and then sutured Hidden X suture with 4-0 silk and needle 19. For the single-blinding of the study, the primary and secondary outcomes are evaluated by one of the project partners.
-
Participants/Inclusion and exclusion criteria
-
Patients 20 to 60 years old, with not-restorable or crowned teeth, with root fractures and extensive decay, with residual roots without apical lesions, soft tissue and buccal bone plate at a normal distance from CEJ, dental atraumatic extraction, and healthy individuals are the inclusion criteria. Smokers, pregnant and lactating women, a history of radiation therapy and chemotherapy, sensitivity to statin drugs, socket type II or III, injecting bisphosphonate, adjacent to the edentulous area are exclusion criteria.
-
Intervention groups
-
Patients are divided into 4 groups. Group A, as control group of spontaneous healing of socket, and groups B, C, and D receive A-PRF +, Rosuvastatin, and A-PRF + / Rosuvastatin, respectively.
-
Main outcome variables
-
Pain, healing of soft and hard tissue of extracted tooth socket, Bucco-lingual width, Mesio-dista, height and buccal wall thickness of extracted tooth socket, Histo-pathology evaluation